Found 2029 results for "cancer"
For the roughly 100,000 men diagnosed annually with intermediate-risk prostate cancer in the U.S., treatment choice increasingly hinges not just on survival…
For the roughly 200,000 men diagnosed with localized prostate cancer each year in the United States, the choice of radiation treatment schedule carries real…
For men diagnosed with localized prostate cancer, the central clinical challenge has never been simply eradicating the tumor — it has been doing so without…
The dream of catching cancer before symptoms appear — across dozens of cancer types simultaneously, with a single blood draw — has long been medicine's holy…
Early cancer detection has long been the holy grail of oncology — catch it before symptoms appear, and survival odds improve dramatically. A large…
Understanding why liver cancer responds so unpredictably to treatment may partly hinge on a problem hiding in plain sight: most molecular profiling averages…
As immune checkpoint inhibitors become a cornerstone of modern oncology, the rheumatic complications they trigger are emerging as a serious and…
For decades, pediatric oncology has accepted that high-risk leukemia requires punishing rounds of chemotherapy — with all the neurotoxicity, infection risk…
Catching the most common human cancer before it becomes visible to the eye — and doing so non-invasively — represents a meaningful shift in dermatologic…
Colorectal cancer kills roughly 900,000 people annually, and its treatment landscape has changed little in over a decade. A convergence of synthetic biology…
Biliary tract cancers — encompassing cholangiocarcinoma and gallbladder cancer — remain among the most lethal gastrointestinal malignancies, with median…
Esophageal cancer ranks among the deadliest malignancies precisely because it is rarely caught early — most patients present with advanced disease, when…
Early cancer detection has long been the holy grail of oncology, but translating a promising blood test into a population-wide screening tool demands a level…
As survival rates for blood cancers climb, the medical community faces a growing challenge: managing the cumulative burden of radiation side effects across…
Docetaxel and other DNA-damaging chemotherapies reliably induce cellular senescence in prostate cancer cells, but the resulting senescence-associated…
For decades, pharmaceutical scientists have relied on laboratory flasks to predict how drug coatings dissolve inside the human gut — a proxy that routinely…
For one of the rarest and most lethal kidney cancers—renal medullary carcinoma (RMC)—clinicians have historically lacked reliable tools to stage disease…
Cardiotoxicity from doxorubicin — one of oncology's most effective but damaging chemotherapeutics — remains a poorly solved problem that forces clinicians to…
The promise of a single blood draw capable of detecting dozens of cancers simultaneously has captivated oncologists and health-conscious adults alike — making…
Cancer prognosis has long relied on staging systems that miss subtle, spatially complex interactions within the tumor microenvironment. A new computational…